Psoriatic Arthiritis (PsA)
About GalvusMet
GalvusMet is a fixed dose combination drugs consists of Vildagliptin/Metformin. I t is indicated in the treatment of type 2 diabetes mellitus, for adult patients who are unable to achieve...
Revolade® (eltrombopag)
Revolade® (eltrombopag) Hematology PharmaceuticalsClinical resources
Basic Succinct Statement
We provide trustworthy information about our marketed drugs. You may view our comprehensive, up-to-date basic succinct...
Tasigna® (nilotinib)
(nilotinib) OncologyJakavi® (ruxolitinib)
JAKAVI (ruxolitinib) JAKAVI (ruxolitinib) is the only licensed oral JAK1 and JAK2 inhibitor targeted therapy approved to treat adult patients with myelofibrosis (MF). 1 Indications: Myelofibrosis (MF) JAKAVI® (ruxolitinib) is indicated for the treatment...When to use JAKAVI (ruxolitinib)
When to use JAKAVI (ruxolitinib)Use JAKAVI as soon as patients are eligible to bring the most benefit to their lives 1-4 ...
Prescribing JAKAVI (ruxolitinib) for MF
Prescribing JAKAVI (ruxolitinib) for MFJAKAVI is recommended for patients with MF with symptomatic splenomegaly and/or MF-...
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable...
×
Ask Speakers
×